To con protection: TIR-domain containing proteins (Tcp) and innate immune evasion

Veterinary Immunology and Immunopathology

Volumn 155, Issue 3, 2013, Pages 147-154

  Patterson, Nicholas J ^a   Werling, Dirk ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Innate Immunity; Tcp; TIR domain; TIR domain containing protein; TLR signalling pathway

Indexed keywords

TIR DOMAIN CONTAINING PROTEIN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

CRYSTAL STRUCTURE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IMMUNE EVASION; INNATE IMMUNITY; NONHUMAN; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); MAMMALIA;

INNATE IMMUNITY; TCP; TIR DOMAIN; TIR-DOMAIN CONTAINING PROTEIN; TLR SIGNALLING PATHWAY;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84883050456     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2013.06.017     Document Type: Review

References (63)

1. Ahmad H., Gubbels R., Ehlers E., Meyer F., Waterbury T., Lin R., Zhang L. Kaposi sarcoma-associated herpesvirus degrades cellular Toll-interleukin-1 receptor domain-containing adaptor-inducing beta-interferon (TRIF). J. Biol. Chem. 2011, 286:7865-7872.
2. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
3. Avbelj M., Horvat S., Jerala R. The role of intermediary domain of MyD88 in cell activation and therapeutic inhibition of TLRs. J. Immunol. 2011, 187:2394-2404.
4. Beutler B. Innate immunity: an overview. Mol. Immunol. 2004, 40:845-859.
5. Bowie A., Kiss-Toth E., Symons J.A., Smith G.L., Dower S.K., O'Neill L.A. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:10162-10167.
6. Chan S.L., Low L.Y., Hsu S., Li S., Liu T., Santelli E., Le Negrate G., Reed J.C., Woods V.L., Pascual J. Molecular mimicry in innate immunity: crystal structure of a bacterial TIR domain. J. Biol. Chem. 2009, 284:21386-21392.
7. Cirl C., Wieser A., Yadav M., Duerr S., Schubert S., Fischer H., Stappert D., Wantia N., Rodriguez N., Wagner H., Svanborg C., Miethke T. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat. Med. 2008, 14:399-406.
8. Couture L.A., Piao W., Ru L.W., Vogel S.N., Toshchakov V.Y. Targeting Toll-like receptor (TLR) signaling by Toll/interleukin-1 receptor (TIR) domain-containing adapter protein/MyD88 adapter-like (TIRAP/Mal)-derived decoy peptides. J. Biol. Chem. 2012, 287:24641-24648.
9. Dunne A., Ejdeback M., Ludidi P.L., O'Neill L.A., Gay N.J. Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88. J. Biol. Chem. 2003, 278:41443-41451.
10. Fekonja O., Avbelj M., Jerala R. Suppression of TLR signaling by targeting TIR domain-containing proteins. Curr. Prot. Pept. Sci. 2012, 13:776-788.
11. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003, 4:491-496.
12. Fitzgerald K.A., Rowe D.C., Barnes B.J., Caffrey D.R., Visintin A., Latz E., Monks B., Pitha P.M., Golenbock D.T. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J. Exp. Med. 2003, 198:1043-1055.
13. Gay N.J., Gangloff M. Structure and function of Toll receptors and their ligands. Annu. Rev. Biochem. 2007, 76:141-165.
14. Gradisar H., Keber M.M., Pristovsek P., Jerala R. MD-2 as the target of curcumin in the inhibition of response to LPS. J. Leukoc. Biol. 2007, 82:968-974.
15. Harte M.T., Haga I.R., Maloney G., Gray P., Reading P.C., Bartlett N.W., Smith G.L., Bowie A., O'Neill L.A. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 2003, 197:343-351.
16. Honda K., Yanai H., Mizutani T., Negishi H., Shimada N., Suzuki N., Ohba Y., Takaoka A., Yeh W.C., Taniguchi T. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:15416-15421.
17. Horng T., Barton G.M., Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2001, 2:835-841.
18. Jann O.C., Werling D., Chang J.S., Haig D., Glass E.J. Molecular evolution of bovine Toll-like receptor 2 suggests substitutions of functional relevance. BMC Evol. Biol. 2008, 8:288.
19. Jiang Z., Georgel P., Li C., Choe J., Crozat K., Rutschmann S., Du X., Bigby T., Mudd S., Sovath S., Wilson I.A., Olson A., Beutler B. Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10961-10966.
20. Jungi T.W., Farhat K., Burgener I.A., Werling D. Toll-like receptors in domestic animals. Cell Tissue Res. 2011, 343:107-120.
21. Kawahara K., Tsukano H., Watanabe H., Lindner B., Matsuura M. Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infect. Immun. 2002, 70:4092-4098.
22. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999, 11:115-122.
23. Kumar H., Kawai T., Akira S. Pathogen recognition in the innate immune response. Biochem. J. 2009, 420:1-16.
24. Lang T., Lo C., Skinner N., Locarnini S., Visvanathan K., Mansell A. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. J. Hepatol. 2011, 55:762-769.
25. Latz E., Verma A., Visintin A., Gong M., Sirois C.M., Klein D.C., Monks B.G., McKnight C.J., Lamphier M.S., Duprex W.P., Espevik T., Golenbock D.T. Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat. Immunol. 2007, 8:772-779.
26. Li C., Zienkiewicz J., Hawiger J. Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway. J. Biol. Chem. 2005, 280:26152-26159.
27. Low L.Y., Mukasa T., Reed J.C., Pascual J. Characterization of a TIR-like protein from Paracoccus denitrificans. Biochem. Biophys. Res. Commun. 2007, 356:481-486.
28. Lysakova-Devine T., Keogh B., Harrington B., Nagpal K., Halle A., Golenbock D.T., Monie T., Bowie A.G. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule. J. Immunol. 2010, 185:4261-4271.
29. Medzhitov R., Preston-Hurlburt P., Kopp E., Stadlen A., Chen C., Ghosh S., Janeway C.A. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 1998, 2:253-258.
30. Monk I.R., Shah I.M., Xu M., Tan M.W., Foster T.J. Transforming the untransformable: application of direct transformation to manipulate genetically Staphylococcus aureus and Staphylococcus epidermidis. mBio 2012, 3.
31. Newman R.M., Salunkhe P., Godzik A., Reed J.C. Identification and characterization of a novel bacterial virulence factor that shares homology with mammalian Toll/interleukin-1 receptor family proteins. Infect. Immun. 2006, 74:594-601.
32. Nigou J., Zelle-Rieser C., Gilleron M., Thurnher M., Puzo G. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. 2001, 166:7477-7485.
33. Novatchkova M., Leibbrandt A., Werzowa J., Neubuser A., Eisenhaber F. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem. Sci. 2003, 28:226-229.
34. Nunez Miguel R., Wong J., Westoll J.F., Brooks H.J., O'Neill L.A., Gay N.J., Bryant C.E., Monie T.P. A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins. PloS ONE 2007, 2:e788.
35. Nyman T., Stenmark P., Flodin S., Johansson I., Hammarstrom M., Nordlund P. The crystal structure of the human toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer. J. Biol. Chem. 2008, 283:11861-11865.
36. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 2007, 7:353-364.
37. Oshiumi H., Matsumoto M., Funami K., Akazawa T., Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 2003, 4:161-167.
38. Piao W., Vogel S.N., Toshchakov V.Y. Inhibition of TLR4 signaling by TRAM-derived decoy peptides in vitro and in vivo. J. Immunol. 2013, 190:2263-2272.
39. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
40. Radhakrishnan G.K., Harms J.S., Splitter G.A. Modulation of microtubule dynamics by a TIR domain protein from the intracellular pathogen Brucella melitensis. Biochem. J. 2011, 439:79-83.
41. Radhakrishnan G.K., Splitter G.A. Biochemical and functional analysis of TIR domain containing protein from Brucella melitensis. Biochem. Biophys. Res. Commun. 2010, 397:59-63.
42. Radhakrishnan G.K., Splitter G.A. Modulation of host microtubule dynamics by pathogenic bacteria. Biomol. Concepts 2012, 3:571-580.
43. Radhakrishnan G.K., Yu Q., Harms J.S., Splitter G.A. Brucella TIR domain-containing protein mimics properties of the Toll-like receptor adaptor protein TIRAP. J. Biol. Chem. 2009, 284:9892-9898.
44. Rana R.R., Simpson P., Zhang M., Jennions M., Ukegbu C., Spear A.M., Alguel Y., Matthews S.J., Atkins H.S., Byrne B. Yersinia pestis TIR-domain protein forms dimers that interact with the human adaptor protein MyD88. Microb. Pathog. 2011, 51:89-95.
45. Ronni T., Agarwal V., Haykinson M., Haberland M.E., Cheng G., Smale S.T. Common interaction surfaces of the toll-like receptor 4 cytoplasmic domain stimulate multiple nuclear targets. Mol. Cell. Biol. 2003, 23:2543-2555.
46. Ryzhakov G., Blazek K., Udalova I.A. Evolution of vertebrate immunity: sequence and functional analysis of the SEFIR domain family member Act1. J. Mol. Evol. 2011, 72:521-530.
47. Sengupta D., Koblansky A., Gaines J., Brown T., West A.P., Zhang D., Nishikawa T., Park S.G., Roop R.M., Ghosh S. Subversion of innate immune responses by Brucella through the targeted degradation of the TLR signaling adapter, MAL. J. Immunol. 2010, 184:956-964.
48. Spear A.M., Loman N.J., Atkins H.S., Pallen M.J. Microbial TIR domains: not necessarily agents of subversion?. Trends Microbiol. 2009, 17:393-398.
49. Spear A.M., Rana R.R., Jenner D.C., Flick-Smith H.C., Oyston P.C., Simpson P., Matthews S.J., Byrne B., Atkins H.S. A Toll/interleukin (IL)-1 receptor domain protein from Yersinia pestis interacts with mammalian IL-1/Toll-like receptor pathways but does not play a central role in the virulence of Y. pestis in a mouse model of bubonic plague. Microbiology 2012, 158:1593-1606.
50. Stack J., Haga I.R., Schroder M., Bartlett N.W., Maloney G., Reading P.C., Fitzgerald K.A., Smith G.L., Bowie A.G. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J. Exp. Med. 2005, 201:1007-1018.
51. Starcic Erjavec M., Jesenko B., Petkovsek Z., Zgur-Bertok D. Prevalence and associations of tcpC, a gene encoding a Toll/interleukin-1 receptor domain-containing protein, among Escherichia coli urinary tract infection, skin and soft tissue infection, and commensal isolates. J. Clin. Microbiol. 2010, 48:966-968.
52. Takeuchi O., Takeda K., Hoshino K., Adachi O., Ogawa T., Akira S. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int. Immunol. 2000, 12:113-117.
53. Toshchakov V.Y., Fenton M.J., Vogel S.N. Cutting edge: differential inhibition of TLR signaling pathways by cell-permeable peptides representing BB loops of TLRs. J. Immunol. 2007, 178:2655-2660.
54. Toshchakov V.Y., Vogel S.N. Cell-penetrating TIR BB loop decoy peptides a novel class of TLR signaling inhibitors and a tool to study topology of TIR-TIR interactions. Expert Opin. Biol. Ther. 2007, 7:1035-1050.
55. Underhill D.M., Ozinsky A., Hajjar A.M., Stevens A., Wilson C.B., Bassetti M., Aderem A. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999, 401:811-815.
56. Walsh C., Gangloff M., Monie T., Smyth T., Wei B., McKinley T.J., Maskell D., Gay N., Bryant C. Elucidation of the MD-2/TLR4 interface required for signaling by lipid IVa. J. Immunol. 2008, 181:1245-1254.
57. Werling D., Jann O.C., Offord V., Glass E.J., Coffey T.J. Variation matters: TLR structure and species-specific pathogen recognition. Trends Immunol. 2009, 30:124-130.
58. Werling D., Jungi T.W. TOLL-like receptors linking innate and adaptive immune response. Vet. Immunol. Immunopathol. 2003, 91:1-12.
59. Wu B., Gong J., Liu L., Li T., Wei T., Bai Z. Evolution of prokaryotic homologues of the eukaryotic SEFIR protein domain. Gene 2012, 492:160-166.
60. Xu Y., Tao X., Shen B., Horng T., Medzhitov R., Manley J.L., Tong L. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 2000, 408:111-115.
61. Yadav M., Zhang J., Fischer H., Huang W., Lutay N., Cirl C., Lum J., Miethke T., Svanborg C. Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence. PLoS Pathog. 2010, 6:e1001120.
62. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003, 301:640-643.
63. Zhang Q., Zmasek C.M., Cai X., Godzik A. TIR domain-containing adaptor SARM is a late addition to the ongoing microbe-host dialog. Dev. Comp. Immunol. 2011, 35:461-468.